Quantum BioPharma Ltd.
QNTM
$30.18
$4.4517.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.88M | -14.20M | -10.24M | -7.47M | -9.85M |
| Total Depreciation and Amortization | 500.10K | 490.50K | 499.90K | 525.90K | 1.50M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 614.90K | -2.92M | -260.30K | -1.83M | -776.30K |
| Change in Net Operating Assets | 10.60M | 9.76M | 3.10M | 3.63M | 1.08M |
| Cash from Operations | -9.16M | -6.88M | -6.89M | -5.14M | -8.05M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 31.80K | 31.80K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.83M | -1.50M | -2.75M | 414.70K | -323.50K |
| Cash from Investing | -2.83M | -1.50M | -2.75M | 446.50K | -291.70K |
| Total Debt Issued | 3.84M | 1.01M | 0.00 | 302.80K | 286.90K |
| Total Debt Repaid | -72.30K | -63.70K | -59.20K | -109.40K | -149.50K |
| Issuance of Common Stock | 10.42M | 10.67M | 9.19M | 2.14M | 308.00K |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.18M | 11.62M | 9.13M | 2.33M | 445.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.19M | 3.24M | -513.70K | -2.36M | -7.89M |